by Danielle Bonadies | Feb 22, 2016 | News
The year 2015 for the Pharma and Biotech industry can be summarized in just three phrases: Pfallergan, Clinton’s Tweet, and CRISPR-Cas9. Reviewing what was an exceptional year, the IMAP report offers insights into merger mania, price pressure in the U.S., and...
by Danielle Bonadies | Feb 11, 2016 | News
Bioscience is Connecticut’s fastest growing business sector. If achieving a career in bioscience is your goal, then join us for The Bioscience Careers Forum at The Jackson Laboratory for Genomic Medicine on 11th March. Bioscience leaders from across Connecticut will...
by Danielle Bonadies | Jan 14, 2016 | News
We are excited to announce that our President and CEO Ellen Matloff has been invited to be a panelist at the FDA’s upcoming March 2 public workshop titled “Patient and Medical Professional Perspectives on the Return of Genetic Test Results.” She will speak on...
by Danielle Bonadies | Apr 23, 2015 | News
A few short years ago, I had no clue how fast things would change for the Previvor Community when I wrote this post about the need for smarter options to screen for, to treat, and to prevent cancer. Times are changing fast for...
by Danielle Bonadies | Mar 26, 2015 | News
Angelina Jolie Pitt’s decision to have her ovaries surgically removed, which the actress and director detailed in The New York Times on March 24, was justified by her family history of breast and ovarian cancer as well as the discovery that she carries a gene...
by Danielle Bonadies | Mar 26, 2015 | News
Ellen T. Matloff, My Gene Counsel President and CEO, was featured in Nature last week discussing how misinterpreted results of genetic testing for cancer risk can result in unnecessary surgery. This story follow’s Angelina Jolie Pitt’s disclosure that she...
